Director, Clinical Program Lead (Oncology)

Location: On-premise in Shanghai, China

Company

hirify.global is a global pharmaceutical company developing medicines and conducting clinical research across multiple therapeutic areas.

What you will do

• Lead China clinical development strategy and delivery as part of global early development programs in oncology.
• Oversee the design, execution, quality, timelines, and operational delivery of clinical trials.
• Assess program risks, implement mitigation plans, and monitor emerging individual and cumulative safety trends.
• Prepare for and participate in regulatory agency meetings, resolve clinical queries, and support regulatory submissions.
• Lead clinical input for Phase 3b/4 programs, commercialization support, product defense, and outcomes research.
• Manage resources and develop, coach, mentor, and retain clinical colleagues and Study Clinicians.

Requirements

• MD, PhD, DVM, MS, PharmD, or an equivalent qualification.
• Proven track record as a successful Study Clinician, preferably in late-phase development or post-approval programs.
• Strong knowledge of clinical trial design, clinical safety review, drug development, and regulatory documentation.
• Ability to collaborate with Medical, Statistics, Clinical Pharmacology, Regulatory, Safety, and other cross-functional stakeholders.
• Experience leading clinical strategy, interpreting clinical data, and delivering high-quality clinical documents.
• Experience managing, coaching, and developing clinical colleagues is preferred.

Nice to have

• Postgraduate training, certification, or fellowship in medicine or drug development.
• Demonstrated scientific productivity through a doctoral thesis, publications, or research reports.
• Thorough understanding of local and international pre- and post-approval clinical trial regulations.

Culture & Benefits

• On-premise work arrangement in Shanghai.
• Cross-regional collaboration with global clinical and medical functions.
• Opportunities to present clinical strategies and data to senior management, governance committees, and external audiences.
• Participation in continuous improvement, education, and clinical staff training initiatives.